ENCORE 601: A phase 2 study of entinostat in combination with pembrolizumab in patients with microsatellite stable metastatic colorectal cancer.

被引：10

作者：

Azad, Nilofer Saba

Shirai, Keisuke

Mcree, Autumn Jackson

Opyrchal, Mateusz

Johnson, Douglas Buckner

Ordentlich, Peter

Brouwer, Susan

Sankoh, Serap

Schmidt, Emmett V.

Meyers, Michael L.

Johnson, Melissa Lynne

机构：

[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[2] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA

[3] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA

[4] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA

[5] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[6] Syndax Pharmaceut, Lexington, MA USA

[7] Syndax Pharmaceut Inc, Waltham, MA USA

[8] Merck & Co Inc, Kenilworth, NJ USA

[9] Syndax Pharmaceut Inc, New York, NY USA

[10] Sarah Cannon Res Inst, Nashville, TN USA

来源：

关键词：

D O I：

10.1200/JCO.2018.36.15_suppl.3557

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3557

引用

页数：1